Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.2137 per EA under NDC 13107021201. Its NADAC has been published 366 times since Oct 2, 2019.
FDA first approved this application on Sep 13, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 7.5 mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107021201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207709FDA Approved
9/13/2018
TE Code
AA
On Market Since
5/6/2015
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has been published 366 times since Oct 2, 2019, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2137 per EA |
|---|---|
| All-time high | $0.6564 (Jun 10, 2020) |
| All-time low | $0.1542 (Jul 17, 2024) |
| 52-week high | $0.2137 |
| 52-week low | $0.1719 |
| Median price | $0.2478 |
| Average price | $0.2926 |
| Largest weekly change | +89.2% (Apr 22, 2020) |
| Weeks tracked | 366 |
| Tracking since | Oct 2, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurolife Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.2137 per EA (NDC 13107021201), effective Sep 30, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has declined 46.9%. It has been tracked across 366 weekly CMS publications since Oct 2, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
Since Oct 2, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has ranged from a low of $0.1542 (Jul 17, 2024) to a high of $0.6564 (Jun 10, 2020), with a median of $0.2478 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, is $0.1741 per EA — about 19% below HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET (NDC 13107021201) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.